Endoscopic Devices - G20

  • G20
  • Revenue in the Endoscopic Devices market market in G20 is projected to reach US$24.77bn in 2024.
  • Revenue is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 6.99%, culminating in a market volume of US$34.73bn by 2029.
  • In the global context, the highest revenue will be generated the United States, which is anticipated to amount to US$10,390.00m in 2024.
  • In Brazil, the growing emphasis on minimally invasive procedures is driving increasing adoption of advanced endoscopic devices within the healthcare sector.

Key regions: Italy, United Kingdom, Netherlands, Germany, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Endoscopic Devices Market within the Medical Devices sector in the G20 is witnessing moderate growth, influenced by factors like technological advancements, increasing demand for minimally invasive procedures, and heightened awareness of patient safety and outcomes.

Customer preferences:
Consumers are increasingly prioritizing personalized healthcare solutions, leading to a growing preference for advanced endoscopic devices that offer tailored treatment options. The rise in health-consciousness, particularly among aging populations in G20 countries, is driving demand for minimally invasive procedures that promise quicker recovery times and reduced hospital stays. Additionally, the cultural shift towards proactive health management is fostering greater acceptance and utilization of innovative endoscopic technologies, enhancing patient engagement and satisfaction.

Trends in the market:
In G20 countries, the Endoscopic Devices Market is experiencing a significant surge in demand for advanced minimally invasive technologies, driven by an aging population and increasing health awareness. As healthcare consumers seek personalized treatment options, manufacturers are innovating to develop endoscopic devices that offer tailored solutions and enhanced patient experiences. Furthermore, the growing acceptance of these technologies is fostering collaboration among healthcare providers, device manufacturers, and regulatory bodies, influencing product development and market access strategies. This trend is expected to reshape care delivery models, emphasizing efficiency and patient-centered approaches.

Local special circumstances:
In Japan, the Endoscopic Devices Market is flourishing, fueled by the nation’s advanced healthcare infrastructure and emphasis on preventive care. The aging population is driving demand for innovative minimally invasive procedures, prompting hospitals to adopt cutting-edge technologies. In Germany, strict regulatory standards ensure high-quality medical devices, fostering trust among healthcare professionals and patients. Meanwhile, in Brazil, cultural beliefs toward traditional medicine influence the adoption of endoscopic procedures, necessitating targeted education campaigns to raise awareness about the benefits of these advanced technologies.

Underlying macroeconomic factors:
The Endoscopic Devices Market is significantly influenced by macroeconomic factors such as global economic stability, national healthcare expenditure, and demographic shifts. Countries with robust healthcare systems, like Japan and Germany, benefit from high healthcare spending, which drives investment in advanced endoscopic technologies. Conversely, in Brazil, economic fluctuations can affect public healthcare funding, impacting the adoption of these devices. Additionally, the growing prevalence of gastrointestinal diseases globally and the emphasis on minimally invasive procedures are catalyzing demand. Regulatory frameworks also play a crucial role, as stringent regulations can enhance product quality and consumer trust, ultimately shaping market dynamics.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)